Literature DB >> 14769142

Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy.

Lisa R Rogers1, Sandra E Remer, Sheela Tejwani.   

Abstract

We report a durable (12-month) response to capecitabine monotherapy, shown clinically, by MRI, and by cerebrospinal fluid analysis, in a patient with leptomeningeal metastasis from breast cancer.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14769142      PMCID： PMC1871963          DOI： 10.1215/S1152851703000334

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


  7 in total

Review 1.  Current concepts in leptomeningeal metastasis.

Authors:  M C Chamberlain
Journal:  Curr Opin Oncol       Date:  1992-06       Impact factor: 3.645

2.  Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer.

Authors:  M L Wang; W K Yung; M E Royce; D F Schomer; R L Theriault
Journal:  Am J Clin Oncol       Date:  2001-08       Impact factor: 2.339

Review 3.  Leptomeningeal carcinomatosis.

Authors:  S A Grossman; M J Krabak
Journal:  Cancer Treat Rev       Date:  1999-04       Impact factor: 12.111

4.  Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment.

Authors:  W Boogerd; A A Hart; J J van der Sande; E Engelsman
Journal:  Cancer       Date:  1991-03-15       Impact factor: 6.860

Review 5.  Leptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy?

Authors:  T Siegal
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

6.  Passage of 5'-dFUrd and its metabolites 5-FU and 5-FUH2 to CSF in a clinical phase 1 study.

Authors:  M S Heier; R Heintz; S D Fosså
Journal:  Acta Neurol Scand       Date:  1986-09       Impact factor: 3.209

7.  Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine.

Authors:  K A Jaeckle; S Phuphanich; M J Bent; R Aiken; T Batchelor; T Campbell; D Fulton; M Gilbert; D Heros; L Rogers; S J O'Day; W Akerley; J Allen; S Baidas; S Z Gertler; H S Greenberg; S LaFollette; G Lesser; W Mason; L Recht; E Wong; M C Chamberlain; A Cohn; M J Glantz; J C Gutheil; B Maria; P Moots; P New; C Russell; W Shapiro; L Swinnen; S B Howell
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640
  7 in total
  18 in total

1.  Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.

Authors:  Hee-Jun Kim; Seock-Ah Im; Bhumsuk Keam; Yu-Jung Kim; Sae-Won Han; Tae Min Kim; Do-Youn Oh; Jee Hyun Kim; Se-Hoon Lee; Eui Kyu Chie; Wonshik Han; Dong-Wan Kim; Tae-You Kim; Dong-Young Noh; Dae Seog Heo; In Ae Park; Yung-Jue Bang; Sung Whan Ha
Journal:  J Neurooncol       Date:  2011-09-22       Impact factor: 4.130

Review 2.  Breast leptomeningeal disease: a review of current practices and updates on management.

Authors:  Nicholas B Figura; Victoria T Rizk; Avan J Armaghani; John A Arrington; Arnold B Etame; Hyo S Han; Brian J Czerniecki; Peter A Forsyth; Kamran A Ahmed
Journal:  Breast Cancer Res Treat       Date:  2019-06-17       Impact factor: 4.872

Review 3.  Optimal management of brain metastases from breast cancer. Issues and considerations.

Authors:  Rupert Bartsch; Anna S Berghoff; Matthias Preusser
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

4.  Contrast-Enhancing Meningeal Lesions Are Associated with Longer Survival in Breast Cancer-Related Leptomeningeal Metastasis.

Authors:  Anne Constanze Regierer; Andrea Stroux; Dagmar Kühnhardt; Annette Dieing; Silvia Lehenbauer-Dehm; Bernd Flath; Kurt Possinger; Jan Eucker
Journal:  Breast Care (Basel)       Date:  2008-04-15       Impact factor: 2.860

5.  DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis.

Authors:  Petra Feyer; Marie-Luise Sautter-Bihl; Wilfried Budach; Jürgen Dunst; Wulf Haase; Wolfgang Harms; Felix Sedlmayer; Rainer Souchon; Frederik Wenz; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2010-01-26       Impact factor: 3.621

6.  Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment.

Authors:  Ticiana Leal; Julie E Chang; Minesh Mehta; H Ian Robins
Journal:  Curr Cancer Ther Rev       Date:  2011-11

7.  Prolonged regression of metastatic leptomeningeal breast cancer that has failed conventional therapy: a case report and review of the literature.

Authors:  Andrew Vincent; Glenn Lesser; Doris Brown; Tamara Vern-Gross; Linda Metheny-Barlow; Julia Lawrence; Michael Chan
Journal:  J Breast Cancer       Date:  2013-03-31       Impact factor: 3.588

8.  Capecitabine therapy of central nervous system metastases from breast cancer.

Authors:  Meltem Ekenel; Adilia M Hormigo; Scott Peak; Lisa M Deangelis; Lauren E Abrey
Journal:  J Neurooncol       Date:  2007-07-05       Impact factor: 4.130

9.  Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients.

Authors:  Cyrus Chargari; Youlia M Kirova; Véronique Diéras; Pablo Castro Pena; Pablo Castro Pena; Francois Campana; Paul H Cottu; JeanYves Pierga; Alain Fourquet
Journal:  J Neurooncol       Date:  2009-01-25       Impact factor: 4.130

10.  Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery.

Authors:  Andrew J Huang; Karen E Huang; Brandi R Page; Diandra N Ayala-Peacock; John T Lucas; Glenn J Lesser; Adrian W Laxton; Stephen B Tatter; Michael D Chan
Journal:  J Neurooncol       Date:  2014-07-22       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.